diabetes mellitus type
diabetes mellitus patients
survival of pancreatic islets
PANcreatic islets immunosuppression free therapy
harvested islets
long-term functionality
insulin injections
transplantation of allogeneic islet cells
years insulin injection free treatment
implantation of allogeneic islet cells
innovative treatment
GMP-grade bioactive microcapsule
best therapy option
years glycaemia regulation
Advanced Therapy Medicinal Products Regulation
current state
long-term complications
tremendous benefit
complex microcapsule
encapsulated approach
GMP-grade microfluidic microencapsulation platform
current encapsulation strategies
adverse immune reactions
immune-system modulation
BIOactive implantable CApsule
lifelong administration of immunosuppressants
innovative extracellular matrix microenvironment reconstruction
key therapeutic issue
situ oxygenation
provisions
prevention of pericapsular fibrotic overgrowth
order
art limits
accordance
clinical trials
unprotected grafts
applicability
Reductions of constant self-control
complete protocol
quality of life
BIOCAPAN
experts
different fields
refresher
implantations necessary
maximum
reproducible way
glycaemic control
project
preclinical validation